about
sameAs
Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infectionMore-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding moleculesThe management of acute bronchitis in childrenVirion Structure of Israeli Acute Bee Paralysis Virus.Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinovirusesDetection of human picornaviruses by multiplex reverse transcription-PCR and liquid hybridization.The infectious march: the complex interaction between microbes and the immune system in asthma.Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infectionEnterovirus infection in Korean children and anti-enteroviral potential candidate agents.Aseptic meningitis epidemic during a West Nile virus avian epizootic.Complete sequence analysis and antiviral screening of medicinal plants for human coxsackievirus a16 isolated in KoreaEvaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid.Molecular methods for diagnosis of viral encephalitisVirion Structure of Black Queen Cell Virus, a Common Honeybee Pathogen.Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrinsThe need for treatment against human parechoviruses: how, why and when?Per aspera ad astra: application of Simplex QSAR approach in antiviral research.SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.Antiviral effect of emodin from Rheum palmatum against coxsakievirus B5 and human respiratory syncytial virus in vitro.In vitro and in vivo studies of the inhibitory effects of emodin isolated from Polygonum cuspidatum on Coxsakievirus B₄.Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.ATP Is an Allosteric Inhibitor of Coxsackievirus B3 Polymerase.Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis.Viral respiratory infection and the link to asthma.In vitro screening of traditionally used medicinal plants in China against enterovirusesConformationally locked bicyclo[4.3.0]nonane carbanucleosides: synthesis and bio-evaluation.Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.Enterovirus 71: epidemiology, pathogenesis and management.The Origin, Dynamic Morphology, and PI4P-Independent Formation of Encephalomyocarditis Virus Replication Organelles.
P2860
Q24306634-1A0DF8B9-A0A3-4677-92A6-F74B2581FD31Q27681644-F7320E68-E60A-4B71-92C1-6597B4425544Q28288887-9FCF4294-C971-4177-8F2C-2A08CF60364BQ30152760-8FC06328-0833-43E4-9A5D-A5455A963DE2Q30448643-6D0CA9B6-37CC-40E2-BA7B-84135674538DQ30449635-3535CB33-CBC4-45D0-B6E9-7159C6D236CAQ30586653-790137DA-2BDA-4CC2-B6F0-7AD518547EF5Q33738124-2753A2BE-38C3-49FD-B357-4402A12755B3Q33752917-AB90D128-5EBB-474E-B17E-D4F1E3605978Q34356430-FEECF3B5-3DCB-4A4F-A2B4-A60702208CF5Q34387141-027209C7-EB77-452E-BCAE-87962DBA632FQ34469094-BAB94C7C-8DD5-4DAF-8426-0BEC8112A575Q34469997-21BABCD1-002F-478C-8671-92C14DB447B7Q35138013-96950EAC-383B-4BE8-8456-74DC87190784Q35155661-EB36A04F-713C-446B-A680-82A8578810C4Q35920649-6DEE398E-DF88-4944-BAD8-F0AD8673266EQ36246864-6E168542-3852-4044-900C-1263A8423D08Q37492311-BFA3BBD7-8DE5-4807-99CA-2AE15599466DQ37816394-F9CD05EF-CD21-4E89-BCAC-A3166016ED95Q37855903-FA201085-D561-4A53-9215-7941BDBC7A23Q38794993-6130FF5D-BD75-4837-A3BE-8FE9FD5EEF5CQ38811618-E781FE41-0BBE-44AA-BE85-A2388C20FD1FQ39090855-28C4A471-2580-4C70-9D25-9882789561FFQ39611676-301AE0BD-D685-46CB-81A4-3C36B87322F8Q40693100-4FE08C86-AC35-4F6C-9991-0992202FAD9CQ40968334-2E5711B6-B05F-40A3-9E67-3E0306A554B8Q41912309-92949C67-D30C-44D8-9770-4110B5999839Q42053478-B727CDA4-1114-4830-AC71-C29C5ACB642AQ42183363-022C422D-EE78-4539-AC17-FFBDAB62749CQ42281820-CD89449D-4858-4C6F-8076-B81A7CD0C110Q43183475-121BD860-7458-40E3-8BDE-BE6C64D4F9CAQ43291847-ED2B0C61-4BF1-4674-B83C-34BAEBFB3FE0Q52718703-89CE5AFD-8A39-48A2-9977-6C8F82B75C53
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of picornavirus infections
@ast
Treatment of picornavirus infections
@en
Treatment of picornavirus infections
@nl
type
label
Treatment of picornavirus infections
@ast
Treatment of picornavirus infections
@en
Treatment of picornavirus infections
@nl
prefLabel
Treatment of picornavirus infections
@ast
Treatment of picornavirus infections
@en
Treatment of picornavirus infections
@nl
P3181
P1433
P1476
Treatment of picornavirus infections
@en
P2093
Harley A Rotbart
P3181
P356
10.1016/S0166-3542(01)00206-6
P407
P577
2002-02-01T00:00:00Z